Obesity Management Market

Obesity Management Market: Global Industry Analysis
and Opportunity Assessment 2017-2027
May 2017
Report Id : REP-GB-587
Status : April-2017
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved
About
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities




Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage




Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
©2015 Future Market Insights, All Rights Reserved
2
Research Methodology (1/2)
Systematic Research Approach
1
Market profiling
2
Formulating discussion guide
3
Developing list of respondents
4
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
Data collection
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data validation
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
5
6
Data analysis
Insights
7
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
(PDF)
Data
Collection




Research &
Intelligence
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Actionable
Insights
A
Primary
Research






B
SOLUTION





Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Primary Research #




Linkedin
Zoominfo
Salesforce
Avention
Business
Solution
Desk
Research
C
Key industry experts
Channel study
Developments
Market dynamics
Products
Conclusions
Company
Analysis
Secondary Research #




Company websites
Company annual
reports
White papers
Financial reports
Paid Publications#




Factiva
GBI
Genios
Meltwater
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
3
Obesity Management Market
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial
support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long
gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes
the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking
better return on investments. In the long run, risks and limitations posed by the high development costs of
obesity drugs are likely to impede the growth of the global obesity management market.
Future Market Insights’ latest publication estimates that the global market for obesity management will
showcase an average growth during the forecast period, 2017-2027. In this period, the market is estimated
to grow from US$ 641.6 Mn in 2016 to US$ 1,078.9 by 2027-end, representing a value CAGR of 4.9%.
Between 2017 and 2027, the global obesity management market is poised to witness an incremental $
opportunity of over US$ 400 Mn.
Request Report [email protected] http://www.futuremarketinsights.com/reports/sample/rep-gb-587
In addition the high costs for developing obesity management drugs, the market is also expected to witness
restraints from poor healthcare infrastructure in emerging markets. Stringent laws imposed upon drug
manufacturers are also impacting the market’s growth. These laws are becoming more ambiguous, resulting
into a slow-down in drug production. Moreover, studies revealing side effects of obesity management drugs
are also causing major disturbance among regulatory bodies and manufacturers. GlaxoSmithKline plc.,
VIVUS, Inc., Novo Nordisk A/S, Arena Pharmaceuticals, Inc., F. Hoffmann La Roche Ltd., and Orexigen,
Therapeutics, Inc. are companies profiled in the report as leading participants of global obesity management
market.
©2015 Future Market Insights, All Rights Reserved
4
Obesity Management Market
A regional analysis of global obesity management market, compiled in the report, projects that North
America’s share on global revenues will surpass 33% towards the end of 2027. North America is anticipated
to emerge as the largest market for obesity management in the world. Western Europe will also be at the
forefront, bringing in an estimated US$ 222 Mn in revenues by 2027-end. Across different regions in the
world, a majority of obesity management drugs will be distributed through hospital pharmacies. With more
than 50% share in global revenues, hospital pharmacies will remain the largest distribution channel for
obesity management drugs throughout the forecast period.
Send An [email protected] http://www.futuremarketinsights.com/askus/rep-gb-587
In terms of surgery, the global demand for obesity management drugs is primarily concentrated towards
treatments namely, gastric bypass surgery and gastric sleeve surgery. In addition to this, the report also
projects that over one-third of global obesity management revenues will be accounted by global sales of
liraglutide drugs. Demand for phentermine and topiramate drugs will also gain traction, registering revenue
growth at 7% CAGR. Nonetheless, fastest revenue growth will be recorded by global sales of bupropion and
naltrexone drugs, revenues from which will surpass US$ 100 Mn by end of 2027.
Browse Full [email protected] http://www.futuremarketinsights.com/reports/obesity-management-market
Click here to
Order a free sample
©2015 Future Market Insights, All Rights Reserved
5
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Obesity Management Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply and Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.6.Scenario Forecast
4.7.Trends
4.8.Regulations Scenario
4.9.Drug Pipeline Assessment
4.10.Epidemiology Analysis
©2015 Future Market Insights, All Rights Reserved
6
Table of Content
5. Global Obesity Management Market Analysis and Forecasts, By Drug Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Drug Type
5.3. Y-o-Y Growth Projections By Drug Type
5.4. Market Value Forecast By Drug Type, 2017–2027
5.4.1. Bupropion and Naltrexone
5.4.2. Orlistat
5.4.3. Lorcaserin
5.4.4. Phentermine and Topiramate
5.4.5. Liraglutide
5.5. Market Attractiveness By Drug Type
6. Global Obesity Management Market Analysis and Forecasts, By Surgery Type
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Surgery Type
6.3. Y-o-Y Growth Projections By Surgery Type
6.4. Market Value Forecast By Surgery Type, 2017–2027
6.4.1. Gastric Bypass Surgery
6.4.2. Adjustable Gastric Banding Surgery
6.4.3. Gastric Sleeve Surgery
6.4.4. Duodenal Switch Surgery
6.4.5. Others
©2015 Future Market Insights, All Rights Reserved
7
Table of Content
7. Global Obesity Management Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Distribution Channel
7.3. Y-o-Y Growth Projections By Distribution Channel
7.4. Market Value Forecast By Distribution Channel, 2017–2027
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies
7.4.3. E- Commerce
7.5. Market Attractiveness By Distribution Channel
8. Global Obesity Management Market Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
Click here to
8.3.4. Eastern Europe
8.3.5. APEJ
Order a free sample
8.3.6. Japan
8.3.7. MEA
8.4. Market Attractiveness By Region
©2015 Future Market Insights, All Rights Reserved
8
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For media queries, contact the press office at
[email protected]
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved
9